~~<i id='74E0C430C5'><strike id='74E0C430C5'><tt id='74E0C430C5'><pre id='74E0C430C5'></pre></tt></strike></i>~~

Home» knowledge» explore

explore

author：fashion 2025-10-02 19:08:11 Page View：959

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby
Next article： The cancer drug shortage isn’t new — and neither are the solutions

Wikipedia

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Pumping milk in bathrooms at health conferences is common

AdobeEventhoughErinBoothwasnotthrilledabouthavingtotraveltoPhiladelphiaforaconferenceatsixweekspostp

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

High breast density mammograms need follow

BENOITDOPPAGNE/BELGAMAG/AFPviaGettyImagesMillionsofAmericanwomenoverage40receiveregularmammogramstos